Status:
COMPLETED
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation
Lead Sponsor:
The Cleveland Clinic
Conditions:
COVID
Corona Virus Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the impact of ascorbic acid (vitamin c) and zinc gluconate in reducing duration of symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19). Pati...
Detailed Description
We aim to see whether ascorbic acid and zinc gluconate which has limited side effect profile and is readily available over the counter can decrease the duration of symptoms seen in patients with new d...
Eligibility Criteria
Inclusion
- Outpatients ≥ 18 years presenting to Cleveland Clinic Health System in Ohio and Florida who test positive for COVID-19 having any of the following symptoms
- Fever or chills
- Shortness of breath or difficulty breathing
- Cough
- Fatigue
- Muscle or body Aches
- Headache
- New loss of taste
- New loss of smell
- Congestion or runny nose
- Nausea
- Vomiting
- Diarrhea
- Women of child bearing potential:
- have had a menstrual period within the past 30 days, or
- have had previous sterilization, or
- are perimenopausal (less than 1 year) who have a negative pregnancy test, or
- women of childbearing potential who do not meet the above and have a negative pregnancy test.
Exclusion
- Patients who are found to be positive during hospitalization
- Patients who reside outside Ohio or Florida.
- Pregnant women:
- Current known pregnancy
- Positive pregnancy test (women of child bearing potential who have not had previous sterilization as defined as hysterectomy or tubal ligation)
- Women of childbearing potential who do not meet the above criteria, last menstrual period greater than 30 days and have a positive pregnancy test.
- Lactating Women
- End stage kidney disease
- Advanced liver disease awaiting transplant
- History of Calcium Oxalate kidney stones.
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2021
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT04342728
Start Date
April 8 2020
End Date
February 11 2021
Last Update
February 16 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Weston, Florida, United States, 33331
2
Cleveland Clinic
Cleveland, Ohio, United States, 44195